ribavirin has been researched along with Cancer of Mouth in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CL; Chen, DS; Chen, PJ; Chou, SW; Kao, JH; Liu, CH; Liu, CJ; Su, TH; Tseng, TC; Yang, HC | 1 |
| Carrozzo, M | 1 |
1 review(s) available for ribavirin and Cancer of Mouth
| Article | Year |
|---|---|
Oral diseases associated with hepatitis C virus infection. Part 2: lichen planus and other diseases.
Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Interferon Type I; Japan; Lichen Planus, Oral; Mediterranean Region; Mouth Mucosa; Mouth Neoplasms; Recombinant Proteins; Ribavirin; T-Lymphocytes | 2008 |
1 other study(ies) available for ribavirin and Cancer of Mouth
| Article | Year |
|---|---|
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer.
Topics: Adult; Aged; Antiviral Agents; Case-Control Studies; Confounding Factors, Epidemiologic; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Mouth Neoplasms; Ribavirin; Taiwan | 2020 |